Pt Dexa Medica is a finished-dose manufacturer. It appears in 39 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), NAFDAC (NG) and NPRA (MY). Its GMP standing is certified by BPOM (ID) and NAFDAC (NG). Customs aggregates show $52K of exports covering 2 molecules to 2 destinations in 2025.
| Regulator | Filings | GMP certificates |
|---|---|---|
| DAV (Vietnam) | 36 | None |
| NAFDAC (NG) | 2 | 1 |
| NPRA (MY) | 1 | None |
| BPOM (ID) | None | 48 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $52K | 2 |
| 2024 | Not reported | $77 | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.
Choose your molecules and target markets. Pt Dexa Medica comes back tiered against every other supplier able to file there.
Start for free